Disease Category Listing (192): Mesothelioma

Click here to sign up to receive emails about new trial listings.

Clinical Trials: Mesothelioma

New York

New York; Columbia Presbyterian
A phase II trial of cisplatin, pemetrexed and bevacizumab in untreated malignant mesothelioma

New York; Columbia Presbyterian
Oxaliplatin (ELOXATINŽ) Plus Gemcitabine as First or Second-line Chemotherapy for Patients with Malignant Pleural or Peritoneal Mesothelioma. A Phase II Clinical Trial

New York; Columbia Presbyterian
Phase II trial of combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for treatment of peritoneal mesothelioma.

New York; Columbia-Presbyterian Medical Center
Open - Label Study of Alimta (pemetrexed) Combination with Cisplatin for Chemonaive Patients with Malignant Pleural Mesothelioma.

Texas

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Mesothelioma

Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: November 25, 2008 at 2:41:03 PM

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]